ABDX — Abingdon Health Share Price
Last Trade - 00:00- £26.80m
- £11.65m
- £11.37m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 3.96 | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 30th Jun | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | 1.39 | 2.27 | 2.28 | 5.24 | 29.9 | 46 | 55.56% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +72.86 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Abingdon Health Ltd is a technology enabled lateral flow diagnostics company focused on developing, manufacturing and commercializing immunoassay tests and reader systems and provides lateral flow assay and reader contract services, and routine manufacturing services. It offers lateral flow reader assay original equipment manufacturer (OEM) solutions. Its lateral flow assay and reader services include later flow assay development, lateral flow manufacturing, quantitative lateral flow test reader customization, pharmaceutical diagnostic solutions and quotation request. Its products are AbC-19 Rapid Test, Nucleic Acid Lateral Flow Immunoassays and Seralite Free Light Chain (FLC) Serum. Abc-19 is a rapid test for the detection of IgG neutralizing antibodies to SARS-CoV-2 (COVID-19). Its Seralite Free Light Chain (FLC) product range is used as an aid in the diagnosis and management of multiple myeloma. The Seralite-FLC product range includes Seralite- FLC Serum and Seralite-FLC Urine.
Directors
- Christopher Hand CHM
- Christopher Yates (43)
- Melanie Ross
- Richard Marlow
- Fiona Smith
- Michael Hunter
- Scott Page
- Last Annual
- June 30th, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- January 16th, 2008
- Public Since
- January 1st, 1970
- No. of Employees
- 119
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 95,699,114
- Address
- York Biotech Campus, Sand Hutton, YORK, YO41 1LZ
- Web
- https://www.abingdonhealth.com/
- Phone
- +44 1214145156
- Auditors
- BDO LLP
Latest News for ABDX
Upcoming events for ABDX
Half Year 2020 Abingdon Health PLC Earnings Release
Similar to ABDX
GENINCODE ORD
London Stock Exchange
OMEGA DIAGNOSTICS ORD
London Stock Exchange
VERICI DX ORD
London Stock Exchange
FAQ
As of Today at 19:54 UTC, shares in Abingdon Health are trading at 28.00p. This share price information is delayed by 15 minutes.
Shares in Abingdon Health last closed at 28.00p and the price had moved by over the past 365 days. In terms of relative price strength the Abingdon Health share price has matched the FTSE All Share Index by over the past year.
There is no consensus recommendation for this security.
Abingdon Health does not currently pay a dividend.
Abingdon Health does not currently pay a dividend.
Abingdon Health does not currently pay a dividend.
To buy shares in Abingdon Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 28.00p, shares in Abingdon Health had a market capitalisation of £26.80m.
Here are the trading details for Abingdon Health:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: ABDX
Based on an overall assessment of its quality, value and momentum Abingdon Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abingdon Health. Over the past six months, its share price has underperformed the FTSE All Share Index by -70.89%.
As of the last closing price of 28.00p, shares in Abingdon Health were trading -61.95% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Abingdon Health PE ratio based on its reported earnings over the past 12 months is 6.85. The shares last closed at 28.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Abingdon Health's management team is headed by:
- Christopher Hand - CHM
- Christopher Yates -
- Melanie Ross -
- Richard Marlow -
- Fiona Smith -
- Michael Hunter -
- Scott Page -
We do not have data on Abingdon Health's shareholders